[Clinical Value of MDHAQ for Disease Activity Assessment in Patients with Rheumatoid Arthritis].

Min Yang,Ying Wang,Qi-bing Xie,Xiao-rnin Cen,Geng Yin
DOI: https://doi.org/10.13464/j.scuxbyxb.2015.02.026
2015-01-01
Abstract:OBJECTIVE:To evaluate the clinical value of the mutidimensional health assessment questionnaire (MDHAQ) for disease activity assessment in patients with rheumatoid arthritis (RA).METHODS:A total of 100 RA patients were recruited in this study and completed the MDHAQ. Clinical data and involved joint function assessment were also collected. Routine assessment of patient index data 3 (RAPID3) was calculated using the MDHAQ. The correlations between RAPID3 and disease activity score 28 (DAS28), simplified disease activity index (CDAI), simplified disease activity index (SDAI) and clinical characteristics were analyzed.RESULTS:RAPID3 was correlated with erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), swollen joints count, tender joints count and overall physician rating (P<0.05). The MDHAQ had a Cronbach's alpha coefficient of 0.821 and a KMO of 0.576. Bartlett's test of sphericity showed P<0.001. RAPID3 was also correlated with DAS28, CDAI and SDAI, with a coefficient of 0.743, 0.697 and 0.640 (P<0.001), respectively.CONCLUSION:MDHAQ is a reliable instrument for disease activity assessment in patients with RA. It is easy to administer in busy clinical settings.
What problem does this paper attempt to address?